Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no!

Eur Respir J. 2018 May 10;51(5):1800730. doi: 10.1183/13993003.00730-2018. Print 2018 May.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • Asthma
  • Eosinophils*
  • Humans
  • Omalizumab*

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • Omalizumab